Walensky RP - Search Results

1

The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort.

Linas BP, Wang B, Smurzynski M, Losina E, Bosch RJ, Schackman BR, Rong J, Sax PE, Walensky RP, Schouten J, Freedberg KA. Linas BP, et al. Among authors: walensky rp. J Viral Hepat. 2011 Jul;18(7):506-12. doi: 10.1111/j.1365-2893.2010.01325.x. Epub 2010 Jun 9. J Viral Hepat. 2011. PMID: 20546501 Free PMC article. Clinical Trial.

2

Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection.

Bassett IV, Giddy J, Wang B, Lu Z, Losina E, Freedberg KA, Walensky RP. Bassett IV, et al. Among authors: walensky rp. HIV Med. 2008 Nov;9(10):863-7. doi: 10.1111/j.1468-1293.2008.00635.x. Epub 2008 Aug 27. HIV Med. 2008. PMID: 18754802 Free PMC article.

3

Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing.

Walensky RP, Losina E, Steger-Craven KA, Freedberg KA. Walensky RP, et al. Arch Intern Med. 2002 Apr 22;162(8):887-92. doi: 10.1001/archinte.162.8.887. Arch Intern Med. 2002. PMID: 11966339

4

AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States.

Walensky RP, Paltiel AD, Freedberg KA. Walensky RP, et al. Clin Infect Dis. 2002 Sep 1;35(5):606-10. doi: 10.1086/341903. Epub 2002 Aug 2. Clin Infect Dis. 2002. PMID: 12173137

5

Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy.

Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Islam R, Freedberg KA. Walensky RP, et al. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):27-37. doi: 10.1097/00126334-200209010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 12352147

6

Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa.

Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Holmes CB, et al. Among authors: walensky rp. Clin Infect Dis. 2003 Mar 1;36(5):652-62. doi: 10.1086/367655. Epub 2003 Feb 17. Clin Infect Dis. 2003. PMID: 12594648 Review.

7

Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.

Kimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KA; Cost-Effectiveness of Preventing AIDS Complications Investigators. Kimmel AD, et al. Among authors: walensky rp. Antivir Ther. 2005;10(1):41-52. Antivir Ther. 2005. PMID: 15751762

8

Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.

Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, Sadownik SN, Freedberg KA. Sax PE, et al. Among authors: walensky rp. Clin Infect Dis. 2005 Nov 1;41(9):1316-23. doi: 10.1086/496984. Epub 2005 Sep 23. Clin Infect Dis. 2005. PMID: 16206108

9

Assessing the impact of federal HIV prevention spending on HIV testing and awareness.

Linas BP, Zheng H, Losina E, Walensky RP, Freedberg KA. Linas BP, et al. Among authors: walensky rp. Am J Public Health. 2006 Jun;96(6):1038-43. doi: 10.2105/AJPH.2005.074344. Epub 2006 May 2. Am J Public Health. 2006. PMID: 16670217 Free PMC article.

10

The survival benefits of AIDS treatment in the United States.

Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. Walensky RP, et al. J Infect Dis. 2006 Jul 1;194(1):11-9. doi: 10.1086/505147. Epub 2006 Jun 1. J Infect Dis. 2006. PMID: 16741877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters